LIQUID BIOPSY MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Liquid Biopsy - Overview The global liquid biopsy market is estimated to accumulate over US$ 3,535.1 million, in terms of value, by the end of 2027. Of the two different test categories for liquid biopsies, one is based on the type of material analyzed in the test, while the other is based on the type of analysis that is performed to detect or monitor cancer. On the basis of material type, the global liquid biopsy market can be segmented into analysis of tumor cells, analysis of free DNA, analysis of Exosomal DNA, and analysis of miRNAs. Moreover, based on the analysis type, the global market can be fragmented into small-scale mutation analysis and targeted deep sequencing, analysis of structural changes, large-scale mutation analysis by next-generation sequencing, and analysis of copy number alterations.
Rising inclination towards non-invasive diagnostic procedures is a vital factor expected to boost the global liquid biopsy market growth over the forecast period. Liquid biopsy offers non-invasive diagnostic tests for detecting cancer. It results in lower morbidity compared to conventional biopsy. Moreover, liquid biopsy can offer a better insight of all the tumor profiles and genetic mutations in a patient. Browse Research Reports: https://www.coherentmarketinsights.com/marketinsight/liquid-biopsy-market-1223
Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Hence, cooperation among bioinformatics specialists, biochemists, and physicians enhances the adoption of liquid biopsy across the globe. Parallel investigation of conventional biopsy and liquid biopsy is required to assess the efficacy of liquid biopsy in diagnosis of cancer. However, access to a limited number of genes acts as a major hindrance for the growth of the global market. Tissue biopsy allows oncologists and doctors to assess multiple genes simultaneously. However, in liquid biopsy, blood and urine tests provides access to one gene at a time, which might not provide accurate companion diagnosis to start the treatment. Market Trends: The CTC (Circulating Tumor Cells) segment in the global liquid biopsy market had acquired US$ 416.7 million in 2019, and is now estimated to reach US$ 1,710.8 million by 2027 at a CAGR of 19.3% during the forecast period. Increasing prevalence of cancer is a major factor propelling growth of the global liquid biopsy market over the forecast period. Request a Sample copy of this reports https://www.coherentmarketinsights.com/insight/request-sample/1223
Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION The blood sample segment led the global liquid biopsy market in 2019, accumulating a 93.6% share, in terms of value. Growing preference for non-invasive diagnostic procedures would potentially propel the growth of the global liquid biopsy market in the foreseeable future. The adoption of Artificial Intelligence (AI) in liquid biopsy is rapidly increasing. For instance, Freenome, an AI genomics company based in the U.S., is focused on developing blood tests to detect the body’s early-warning signs of cancer, using AI. In October 2018, the company presented early data in R&D for using machine learning to detect colorectal cancer at its earliest stages. Competitive Backdrop: The well-known companies operating in the global liquid biopsy market include Biocept, Inc., Qiagen N.V., Trovagene, Inc., Janssen Global Services, LLC, MDxHealth SA, Natera, Inc., F. Hoffmann-La Roche Ltd., Silicon Biosystems, Pathway Genomics Corporation, and Sysmex Corporation.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1223
Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved